19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace.

SCAMHC serves all individuals regardless of inability to pay. Discounts for essential services are offered based on family size and income. For more information, contact (334) 222-2523 or our 24/7 Helpline at 1-877-530-0002.



powered by centersite dot net
Child & Adolescent Development: Overview
Basic InformationMore InformationLatest News
Many Marijuana Vendors Aim Advertising at Kids: StudyHeart Function Rebounds for Kids With COVID-Linked MIS-CWhich Kids Are Most Vulnerable to Severe COVID-19?At-Home COVID Tests Accurate for Ki​ds: StudyCDC Study Shows Power of Flu Vaccine for KidsCOVID Hospitalizations Rising in Kids Too Young for VaccineNearly 600,000 U.S. Kids Had COVID Last WeekWhite House to Give Schools 10 Million Free COVID Tests Every MonthKids' Behavior Worsened With Remote Learning: StudyLater School Start Times Boost Parents' Health, TooUrban Air Pollution Drives Millions of Cases of Asthma in KidsCDC Backs Boosters for High-Risk Kids Aged 5-11, Shorter Time Between ShotsA Better Way to Correct Severe Scoliosis in Kids?Getting Your Child Their Vaccine?  Some Tips on Easing Needle FearsU.S. Hospitals Seeing Record Numbers of Young COVID PatientsSevere Illness in Children Brings Hardship for FamiliesReal-World Data Confirms Pfizer Vaccine Safe for Kids Ages 5-11Family Factors Affect Child's Odds for Cleft PalateAs Omicron Spreads, Child Hospitalizations Climb 30% in Past WeekNew Clues to Sudden Unexplained Deaths in Young KidsSevere Illness in a Child Takes Big Toll on Parents, Siblings: StudyProgram Aims to Get Lifesaving Drugs to Kids With Cancer in Poorer CountriesSchool COVID Outbreaks Drop When Adults Wear Masks, Study FindsMany Overweight Kids Already Have Hardened Arteries, DiabetesCDC Supports 'Test-to-Stay' Strategy for SchoolsJunk Food Ads Reaching Kids Through Livestream Gaming PlatformsWhat Does 'Long COVID' Look Like in Kids?New Drug a Good Treatment Option for Severe Asthma in KidsFebrile Seizures: How to Protect Your ChildNew Treatment Greatly Boosts Survival for Kids With a Rare, Aggressive CancerRisk of Vision Trouble Rises in Children With Type 2 DiabetesMore Time Outdoors May Lower Risk of MS in YouthNew Asthma Drug Helps Kids, But Price Tag Is HighUS Surgeon General Report Warns of Mental Health Crisis Hitting YouthAnother Benefit to Asthma Control for Kids: Less Bullying1 in 3 U.S. Children Lack Adequate Health InsuranceWhat's Behind Unexplained Epilepsy in Kids? A Gene Test May TellIs the Mumps Vaccine Becoming Less Effective?Autism Now Diagnosed in 1 in Every 44 Children, CDC SaysKids With Uncontrolled Asthma at Higher Odds for Severe COVID-19Nearly 7% of U.S. Kids Have Had a Head Injury or ConcussionAre Your Holiday Gifts on the 'Noisy Toy List'?Many Kids, Teens Think Girls Don't Care About Computer ScienceMost Parents Say Their Kids Aren't Thankful Enough: PollPandemic Curbed Kids' Efforts to Lose Excess WeightClimate Change May Not Increase Allergies in Kids With Asthma: StudyNearly 10% of Younger Kids Have Gotten First COVID Vaccine DoseAHA News: Family-Based Programs Targeting Childhood Obesity Can Be Good for Parents, TooCases of Children's Severe COVID-Linked Illness Were Worse in Second WaveFace Masks Don't Hide Emotions From Kids: Study
Questions and AnswersVideosLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses

Real-World Data Confirms Pfizer Vaccine Safe for Kids Ages 5-11

HealthDay News
Updated: Dec 30th 2021

new article illustration

THURSDAY, Dec. 30, 2021 (HealthDay News) -- New U.S. data based on nearly 9 million doses of the Pfizer-BioNTech COVID-19 vaccine delivered to kids ages 5 to 11 shows no major safety issues, according to researchers at the U.S. Centers for Disease Control and Prevention.

The vaccine was first authorized for use in this age group in October. Now the new study shows that these "preliminary safety findings are similar to those described in the clinical trials" that led to the vaccine's emergency approval, according to a team led by Anne Hause of the CDC's COVID-19 Response Team.

The report was based on data collected by the agency's Vaccine Adverse Reporting System (VAERS). It relies on smartphone messages from parents and other guardians of children to alert the CDC of any health "events" occurring after a child's vaccination.

During a six-week period after the shots' approval (Nov. 3 through Dec. 19), VAERS received 4,249 reports of adverse events after Pfizer vaccination in kids ages 5-11.

The vast majority -- 97.6% -- "were not serious," Hause's team said, and consisted largely of reactions often seen after routine immunizations, such arm pain at the site of injection, or some transient fatigue or headache.

Parents "should be advised that local and systemic reactions [like these] are expected after vaccinations," the CDC investigators said.

More severe effects were exceedingly rare. Out of about 8.7 million vaccinations delivered during the study period, 100 such reports were received by VAERS. They included 29 reports of fever, 21 reports of vomiting, and 10 serious reports of seizure, although in some of these seizure cases, other underlying factors were potentially involved, the CDC team said.

There were only 15 "preliminary reports" of the rare heart condition known as myocarditis, an inflammation of the heart that has also been noted, in rare cases, among teens and young people who've received the COVID vaccine.

Two girls, aged 5 and 6, who'd received the Pfizer vaccine died during the study period. Hause and colleagues noted that both children "had complicated medical histories and were in fragile health before vaccination," and they added that "none of the data suggested a causal association between death and vaccination."

Although pediatric deaths from COVID-19 remain rare, hundreds of American children have died from the illness since the pandemic began. So, Hause's team emphasized that "vaccination is the most effective way to prevent COVID-19 infection" in kids.

Dr. Henry Bernstein is a pediatrician at Cohen Children’s Medical Center in New Hyde Park, N.Y. Reading over the new report, he said the new study "clearly supports giving the vaccine to children 5-11 years of age.

"Yes, there can be local [for example, redness, soreness or swelling at the site of the shot] and systemic [fever, tiredness, headache] reactions after a child receives the vaccine, especially after the second dose," Bernstein said. "In fact, about one-third to one-half of children may experience some of these side effects."

However, "parents should know that the side effects generally are not serious and tend not to last very long at all," Bernstein said.

Of course, some parents may be concerned about the rare risk for myocarditis. But "these data are incredibly reassuring [on] how rare this condition is in 5- to 11-year-old children, how mild the myocarditis is if it does occur, and how quickly the children tend to recover," Bernstein said. "The vaccine also has not caused heart attacks or death."

His advice? "Please have your 5- to 11-year-old children vaccinated as soon as possible," Bernstein said. "This is the best way to keep them (and their families) safe and well during the ongoing pandemic."

The new study was published in the Dec. 31 issue of the CDC journal Morbidity and Mortality Weekly Report.

More information

Find out more about child vaccination for COVID-19 at the American Academy of Pediatrics.

SOURCES: Henry Bernstein, DO, MHCM, pediatrician, Cohen Children’s Medical Center, New Hyde Park, N.Y.; Morbidity and Mortality Weekly Report, Dec. 31, 2021